United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0781-2176_977d4566-20b3-4909-ad00-6cbea017798d
- Product NDC
- 0781-2176
- Form
- CAPSULE
- Composition / generic term
- Cefdinir
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070406
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (0781-2176-01) · 0781-2176-01
- 60 CAPSULE in 1 BOTTLE (0781-2176-60) · 0781-2176-60
- 3 CARTON in 1 CARTON (0781-2176-64) / 1 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK · 0781-2176-64
- 5 BLISTER PACK in 1 CARTON (0781-2176-69) / 10 CAPSULE in 1 BLISTER PACK · 0781-2176-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →